The diabetes epidemic demands a powerful response from leaders in the diabetes community, nationally and globally. Joslin Diabetes Center, an affiliate of Harvard Medical School will convene all stakeholders for a groundbreaking, immersive activity over 3 days in September called Diabetes Innovation 2012 (September 23-25, 2012 at the Hyatt Crystal City in Arlington, VA).
Diabetes Innovation 2012 will act as a powerful catalyst for ideas, partnerships and collaborations. It will provoke thought, innovation and action that address the cost, productivity and quality-of-life impact of diabetes on our society by bringing together all stakeholders: payers, purchasers, providers, industry, government, research, patients, consumers, technologists, developers, and funders.
This unprecedented event will provide a powerful foundation for sustained advancement in all facets of diabetes prevention, treatment and payment reforms including social media and gaming, translational research breakthroughs, food sourcing, distribution to mobile patient technologies and everything in between.
The conference gives leaders and innovators from all sectors the opportunity to feature the many innovations in prevention, delivery and adherence as well as in process and policy. Among over 80 faculty, and hundreds of audience members, from industry and the payer, provider and purchaser community and academia, leaders from many of the most important government agencies (AHRQ, PCORI, NIH, CDC, FDA, CMS, CMMI) will be on hand to encourage open dialogue and collaboration to speed system improvements.
To sponsor, exhibit or register for Diabetes Innovation 2012, please visit www.diabetesinnovation.org.